Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Tempest Therapeutics Inc. Stock

Price
Target price
-

-

-
-
-
-
 
WKN: A3CSM8 / Symbol: TPST / Name: Tempest Therapeutics / Stock / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Tempest Therapeutics Inc. in the next few years
Wizard

Tempest Therapeutics Inc. Stock

For the coming years our community has positive and negative things to say abot the Tempest Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Valuation (undervalued/overvalued)" there were negative voices in the community.
What does Tempest Therapeutics do?

Pros and Cons of Tempest Therapeutics Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

The financials of Tempest Therapeutics (TPST), while intriguing, present a rather mixed picture. With the biotech industry often characterized by volatility and uncertainty, it’s essential to delve deep into the numbers to grasp the overall financial health of the company. Tempest Therapeutics is currently navigating a challenging landscape, and an examination of its financial ratios, valuation metrics, and overall performance reveals both potential opportunities and significant risks.

*Pros: *

Enterprise Value Insight: The Enterprise Value (EV) of approximately $56 million indicates the total value of the company, accounting for its market capitalization along with debt and excluding cash and cash equivalents. This number can provide insightful context when evaluating how the market values Tempest Therapeutics relative to its operational performance.

Show more

Comments

Prediction Buy
Perf. (%) -49.89%
Target price 4.731
Change
Ends at 13.11.25

Tempest Therapeutics, Inc. (NASDAQ: TPST) had its price target lowered by analysts at Piper Sandler from $8.00 to $5.00. They now have an "overweight" rating on the stock.
Ratings data for TPST provided by MarketBeat
Show more

Piper Sandler 
0
Report Share
13.11.24
Prediction Buy
Perf. (%) -49.25%
Target price 44.180
Change
Ends at 13.11.25

Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $47.00 price target on the stock.
Ratings data for TPST provided by MarketBeat
Show more

HC Wainwright 
0
Report Share
13.11.24

Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for TPST provided by MarketBeat
Show more

William Blair 
0
Report Share
13.11.24 Buy -49.25%
Show more
Not a member yet? Sign up for free!